Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma	Disease Attributes, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Recurrence, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Recruiting	Phase 3	2021-03-04		NCT04778956

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital, Sun Yat-Sen University	113
First People's Hospital of Foshan	44
Nanfang Hospital, Southern Medical University	248
Sun Yat-sen University	606
Tenth Affiliated Hospital, Sun Yat-sen University	1
Zhongshan People's Hospital, Guangdong, China	46

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Nanfang Hospital of Southern Medical University	Guangzhou	China	37
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The Fifth Affiliated Hospital of Guangzhou Medical University	Guangzhou	China	2
The First Affiliated Hospital, Sun Yat-sen University	Guangzhou	China	32
The First People's Hospital of Foshan	Guangzhou	China	2
The Tenth Affiliated Hospital, Sun Yat-Sen University	Nanchang	China	1
Zhongshan People's Hospital	Zhongshan	China	14